QTY Fc fusion receptor proteins
US11939368B2 · kind B2 · utility
0Cited by
6References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 29, 2022 |
| Grant date | Mar 26, 2024 |
| Priority date | — |
| Expiry date | Jul 29, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to QTY CCR9 and CXCR2 variant Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.